Biotech Anchors Boston Economy Amid CRE Headwinds
The recent $10.6 billion deal for a GSK lung cancer drug approval, coupled with Lilly’s advanced data on its obesity […]
New policies and their financial implications
The recent $10.6 billion deal for a GSK lung cancer drug approval, coupled with Lilly’s advanced data on its obesity […]
The economic picture across Greater Boston in mid-2026 is defined by a profound divergence: while national labor metrics suggest stability,
The Greater Boston economy presents a study in divergence: world-class valuations are colliding with cooling physical assets. While Cambridge’s biotech
Despite persistent inflation pressures, Greater Boston’s economic landscape presents a nuanced picture of resilience mixed with localized cooling. While national
Despite a robust national labor market—with the Unemployment Rate holding at 4.2% as of June 1st, and Nonfarm Payrolls growing
The confluence of sticky inflation and elevated borrowing costs continues to define the investment calculus for Greater Boston’s commercial real
Industrial Boom vs. Downtown Decline: Where is Capital Flowing? As Greater Boston navigates persistent cost pressures and a cooling labor